Jul 9 |
Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024
|
Jun 28 |
Do Options Traders Know Something About Organon (OGN) Stock We Don't?
|
Jun 3 |
Organon (OGN) Just Overtook the 20-Day Moving Average
|
May 24 |
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
|
May 11 |
Organon Graduates From Spinoff Skepticism, With A Yield Above 5%
|
May 8 |
Organon Q1 Earnings: Does The $1 Billion Debt Offering Signal Trouble?
|
May 8 |
Organon announces pricing of $1 billion senior notes offering
|
May 8 |
Organon Announces Pricing of $1.0 Billion Senior Notes Offering
|
May 7 |
Four Reasons Why Organon Stock Is A Good Buy
|
May 7 |
Organon plans to offer $1B in senior notes
|